Follow the people · Insider
Joseph Shulman
Joseph Shulman files insider transactions with the SEC as a chief technical officer of Rhythm Pharmaceuticals (RYTM). We hold 1 disclosed purchase or sale filed since 11 February 2022, 1 of them in the last 90 days.
- Files forRYTM
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure17 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 9 February 2022 — 13 August 2026Chief Technical Officer · Rhythm Pharmaceuticals (RYTM)131 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 2,024 shares of Rhythm PharmaceuticalsSEC Form 417 August 2026Common Stock · traded 13 August 2026 · filed 17 August 2026
- ▼ sold on the open market 5,079 shares of Rhythm PharmaceuticalsSEC Form 417 August 2026Common Stock · traded 13 August 2026 · filed 17 August 2026
- exercised options over 2,024 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 417 August 2026Stock Options (Right to Buy) · traded 13 August 2026 · filed 17 August 2026
- was granted 15,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2026Restricted Stock Units · traded 11 February 2026 · filed 13 February 2026
- was granted 22,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2026Stock Options (Right to Buy) · traded 11 February 2026 · filed 13 February 2026
- was granted 15,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2026Restricted Stock Units · traded 11 February 2026 · filed 13 February 2026
- was granted 22,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2026Stock Options (Right to Buy) · traded 11 February 2026 · filed 13 February 2026
- exercised options over 16,968 shares of Rhythm PharmaceuticalsSEC Form 43 February 2026Common Stock · traded 1 February 2026 · filed 3 February 2026
- had shares withheld for tax on 6,507 shares of Rhythm PharmaceuticalsSEC Form 43 February 2026Common Stock · traded 1 February 2026 · filed 3 February 2026
- exercised options over 2,656 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 1 February 2026 · filed 3 February 2026
- exercised options over 2,656 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 1 February 2026 · filed 3 February 2026
- exercised options over 3,937 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 1 February 2026 · filed 3 February 2026
- exercised options over 4,125 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 1 February 2026 · filed 3 February 2026
- exercised options over 6,250 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 1 February 2026 · filed 3 February 2026
- exercised options over 3,937 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 1 February 2026 · filed 3 February 2026
- exercised options over 4,125 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 1 February 2026 · filed 3 February 2026
- exercised options over 6,250 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 1 February 2026 · filed 3 February 2026
- exercised options over 16,968 shares of Rhythm PharmaceuticalsSEC Form 43 February 2026Common Stock · traded 1 February 2026 · filed 3 February 2026
- had shares withheld for tax on 6,507 shares of Rhythm PharmaceuticalsSEC Form 43 February 2026Common Stock · traded 1 February 2026 · filed 3 February 2026
- exercised options over 9,748 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 November 2025Stock Options (Right to Buy) · traded 30 October 2025 · filed 3 November 2025
- exercised options over 9,748 shares of Rhythm PharmaceuticalsSEC Form 43 November 2025Common Stock · traded 30 October 2025 · filed 3 November 2025
- ▼ sold on the open market 9,748 shares of Rhythm PharmaceuticalsSEC Form 43 November 2025Common Stock · traded 30 October 2025 · filed 3 November 2025
- exercised options over 2,094 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 430 October 2025Stock Options (Right to Buy) · traded 28 October 2025 · filed 30 October 2025
- exercised options over 721 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 430 October 2025Stock Options (Right to Buy) · traded 28 October 2025 · filed 30 October 2025
- exercised options over 2,094 shares of Rhythm PharmaceuticalsSEC Form 430 October 2025Common Stock · traded 28 October 2025 · filed 30 October 2025
- exercised options over 721 shares of Rhythm PharmaceuticalsSEC Form 430 October 2025Common Stock · traded 28 October 2025 · filed 30 October 2025
- ▼ sold on the open market 2,815 shares of Rhythm PharmaceuticalsSEC Form 430 October 2025Common Stock · traded 28 October 2025 · filed 30 October 2025
- exercised options over 2,093 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 420 October 2025Stock Options (Right to Buy) · traded 16 October 2025 · filed 20 October 2025
- exercised options over 12,344 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 420 October 2025Stock Options (Right to Buy) · traded 16 October 2025 · filed 20 October 2025
- exercised options over 2,093 shares of Rhythm PharmaceuticalsSEC Form 420 October 2025Common Stock · traded 16 October 2025 · filed 20 October 2025
- exercised options over 12,344 shares of Rhythm PharmaceuticalsSEC Form 420 October 2025Common Stock · traded 16 October 2025 · filed 20 October 2025
- ▼ sold on the open market 2,693 shares of Rhythm PharmaceuticalsSEC Form 420 October 2025Common Stock · traded 16 October 2025 · filed 20 October 2025
- ▼ sold on the open market 8,332 shares of Rhythm PharmaceuticalsSEC Form 420 October 2025Common Stock · traded 16 October 2025 · filed 20 October 2025
- ▼ sold on the open market 3,412 shares of Rhythm PharmaceuticalsSEC Form 420 October 2025Common Stock · traded 16 October 2025 · filed 20 October 2025
- exercised options over 2,094 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 44 September 2025Stock Options (Right to Buy) · traded 2 September 2025 · filed 4 September 2025
- exercised options over 14,687 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 44 September 2025Stock Options (Right to Buy) · traded 2 September 2025 · filed 4 September 2025
- exercised options over 2,094 shares of Rhythm PharmaceuticalsSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- exercised options over 14,687 shares of Rhythm PharmaceuticalsSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- ▼ sold on the open market 16,781 shares of Rhythm PharmaceuticalsSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- exercised options over 4,188 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 425 August 2025Stock Options (Right to Buy) · traded 21 August 2025 · filed 25 August 2025
- exercised options over 4,188 shares of Rhythm PharmaceuticalsSEC Form 425 August 2025Common Stock · traded 21 August 2025 · filed 25 August 2025
- ▼ sold on the open market 4,188 shares of Rhythm PharmaceuticalsSEC Form 425 August 2025Common Stock · traded 21 August 2025 · filed 25 August 2025
- exercised options over 3,984 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 August 2025Stock Options (Right to Buy) · traded 11 August 2025 · filed 13 August 2025
- exercised options over 3,984 shares of Rhythm PharmaceuticalsSEC Form 413 August 2025Common Stock · traded 11 August 2025 · filed 13 August 2025
- ▼ sold on the open market 3,984 shares of Rhythm PharmaceuticalsSEC Form 413 August 2025Common Stock · traded 11 August 2025 · filed 13 August 2025
- exercised options over 7,969 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 411 July 2025Stock Options (Right to Buy) · traded 9 July 2025 · filed 11 July 2025
- exercised options over 7,969 shares of Rhythm PharmaceuticalsSEC Form 411 July 2025Common Stock · traded 9 July 2025 · filed 11 July 2025
- ▼ sold on the open market 3,984 shares of Rhythm PharmaceuticalsSEC Form 411 July 2025Common Stock · traded 9 July 2025 · filed 11 July 2025
- ▼ sold on the open market 3,985 shares of Rhythm PharmaceuticalsSEC Form 411 July 2025Common Stock · traded 9 July 2025 · filed 11 July 2025
- was granted 25,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 419 February 2025Restricted Stock Units · traded 14 February 2025 · filed 19 February 2025
- was granted 37,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 419 February 2025Stock Options (Right to Buy) · traded 14 February 2025 · filed 19 February 2025
- exercised options over 4,125 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 419 February 2025Restricted Stock Units · traded 16 February 2025 · filed 19 February 2025
- exercised options over 4,125 shares of Rhythm PharmaceuticalsSEC Form 419 February 2025Common Stock · traded 16 February 2025 · filed 19 February 2025
- ▼ sold on the open market 1,228 shares of Rhythm PharmaceuticalsSEC Form 419 February 2025Common Stock · traded 19 February 2025 · filed 19 February 2025
- ▼ sold on the open market 462 shares of Rhythm PharmaceuticalsSEC Form 414 February 2025Common Stock · traded 12 February 2025 · filed 14 February 2025
- ▼ sold on the open market 7 shares of Rhythm PharmaceuticalsSEC Form 414 February 2025Common Stock · traded 12 February 2025 · filed 14 February 2025
- exercised options over 2,656 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 411 February 2025Restricted Stock Units · traded 9 February 2025 · filed 11 February 2025
- exercised options over 1,562 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 411 February 2025Restricted Stock Units · traded 11 February 2025 · filed 11 February 2025
- exercised options over 2,656 shares of Rhythm PharmaceuticalsSEC Form 411 February 2025Common Stock · traded 9 February 2025 · filed 11 February 2025
- exercised options over 1,562 shares of Rhythm PharmaceuticalsSEC Form 411 February 2025Common Stock · traded 11 February 2025 · filed 11 February 2025
- ▼ sold on the open market 791 shares of Rhythm PharmaceuticalsSEC Form 411 February 2025Common Stock · traded 11 February 2025 · filed 11 February 2025
- ▼ sold on the open market 3 shares of Rhythm PharmaceuticalsSEC Form 411 February 2025Common Stock · traded 11 February 2025 · filed 11 February 2025
- exercised options over 3,938 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 44 February 2025Restricted Stock Units · traded 1 February 2025 · filed 4 February 2025
- exercised options over 3,938 shares of Rhythm PharmaceuticalsSEC Form 44 February 2025Common Stock · traded 1 February 2025 · filed 4 February 2025
- ▼ sold on the open market 1,281 shares of Rhythm PharmaceuticalsSEC Form 44 February 2025Common Stock · traded 4 February 2025 · filed 4 February 2025
- exercised options over 65,175 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 November 2024Stock Option (right to buy) · traded 9 February 2024 · filed 13 November 2024
- exercised options over 3,985 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 November 2024Stock Option (right to buy) · traded 9 February 2024 · filed 13 November 2024
- exercised options over 65,175 shares of Rhythm PharmaceuticalsSEC Form 413 November 2024Common Stock · traded 9 February 2024 · filed 13 November 2024
- exercised options over 3,985 shares of Rhythm PharmaceuticalsSEC Form 413 November 2024Common Stock · traded 9 February 2024 · filed 13 November 2024
- exercised options over 7,969 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 November 2024Stock Option (right to buy) · traded 11 November 2024 · filed 13 November 2024
- exercised options over 5,312 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 November 2024Stock Option (right to buy) · traded 11 November 2024 · filed 13 November 2024
- exercised options over 7,969 shares of Rhythm PharmaceuticalsSEC Form 413 November 2024Common Stock · traded 11 November 2024 · filed 13 November 2024
- exercised options over 5,312 shares of Rhythm PharmaceuticalsSEC Form 413 November 2024Common Stock · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 6,604 shares of Rhythm PharmaceuticalsSEC Form 413 November 2024Common Stock · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 5,977 shares of Rhythm PharmaceuticalsSEC Form 413 November 2024Common Stock · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 700 shares of Rhythm PharmaceuticalsSEC Form 413 November 2024Common Stock · traded 11 November 2024 · filed 13 November 2024
- exercised options over 10,468 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 418 July 2024Stock Option (right to buy) · traded 16 July 2024 · filed 18 July 2024
- exercised options over 10,468 shares of Rhythm PharmaceuticalsSEC Form 418 July 2024Common Stock · traded 16 July 2024 · filed 18 July 2024
- ▼ sold on the open market 10,468 shares of Rhythm PharmaceuticalsSEC Form 418 July 2024Common Stock · traded 16 July 2024 · filed 18 July 2024
- exercised options over 5,313 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 416 July 2024Stock Option (right to buy) · traded 12 July 2024 · filed 16 July 2024
- exercised options over 5,313 shares of Rhythm PharmaceuticalsSEC Form 416 July 2024Common Stock · traded 12 July 2024 · filed 16 July 2024
- ▼ sold on the open market 5,313 shares of Rhythm PharmaceuticalsSEC Form 416 July 2024Common Stock · traded 12 July 2024 · filed 16 July 2024
- exercised options over 3,984 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 May 2024Stock Option (right to buy) · traded 9 May 2024 · filed 13 May 2024
- exercised options over 3,984 shares of Rhythm PharmaceuticalsSEC Form 413 May 2024Common Stock · traded 9 May 2024 · filed 13 May 2024
- ▼ sold on the open market 3,484 shares of Rhythm PharmaceuticalsSEC Form 413 May 2024Common Stock · traded 9 May 2024 · filed 13 May 2024
- ▼ sold on the open market 500 shares of Rhythm PharmaceuticalsSEC Form 413 May 2024Common Stock · traded 9 May 2024 · filed 13 May 2024
- ▼ sold on the open market 18,235 shares of Rhythm PharmaceuticalsSEC Form 422 March 2024Common Stock · traded 21 March 2024 · filed 22 March 2024
- ▼ sold on the open market 15,515 shares of Rhythm PharmaceuticalsSEC Form 419 March 2024Common Stock · traded 19 March 2024 · filed 19 March 2024
- was granted 16,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 421 February 2024Restricted Stock Units · traded 16 February 2024 · filed 21 February 2024
- was granted 50,250 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 421 February 2024Stock Option (Right to Buy) · traded 16 February 2024 · filed 21 February 2024
- was granted 33,750 shares of Rhythm PharmaceuticalsSEC Form 421 February 2024Common Stock · traded 16 February 2024 · filed 21 February 2024
- ▼ sold on the open market 1,865 shares of Rhythm PharmaceuticalsSEC Form 415 February 2024Common Stock · traded 13 February 2024 · filed 15 February 2024
- ▼ sold on the open market 1,089 shares of Rhythm PharmaceuticalsSEC Form 415 February 2024Common Stock · traded 14 February 2024 · filed 15 February 2024
- exercised options over 2,656 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2024Restricted Stock Units · traded 9 February 2024 · filed 13 February 2024
- exercised options over 69,190 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2024Stock Option (right to buy) · traded 9 February 2024 · filed 13 February 2024
- exercised options over 1,562 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2024Restricted Stock Units · traded 11 February 2024 · filed 13 February 2024
- exercised options over 2,656 shares of Rhythm PharmaceuticalsSEC Form 413 February 2024Common Stock · traded 9 February 2024 · filed 13 February 2024
- exercised options over 69,190 shares of Rhythm PharmaceuticalsSEC Form 413 February 2024Common Stock · traded 9 February 2024 · filed 13 February 2024
- ▼ sold on the open market 100 shares of Rhythm PharmaceuticalsSEC Form 413 February 2024Common Stock · traded 9 February 2024 · filed 13 February 2024
- ▼ sold on the open market 48,177 shares of Rhythm PharmaceuticalsSEC Form 413 February 2024Common Stock · traded 9 February 2024 · filed 13 February 2024
- ▼ sold on the open market 23,397 shares of Rhythm PharmaceuticalsSEC Form 413 February 2024Common Stock · traded 9 February 2024 · filed 13 February 2024
- ▼ sold on the open market 100 shares of Rhythm PharmaceuticalsSEC Form 413 February 2024Common Stock · traded 9 February 2024 · filed 13 February 2024
- exercised options over 1,562 shares of Rhythm PharmaceuticalsSEC Form 413 February 2024Common Stock · traded 11 February 2024 · filed 13 February 2024
- ▼ sold on the open market 791 shares of Rhythm PharmaceuticalsSEC Form 413 February 2024Common Stock · traded 12 February 2024 · filed 13 February 2024
- ▼ sold on the open market 473 shares of Rhythm PharmaceuticalsSEC Form 413 February 2024Common Stock · traded 13 February 2024 · filed 13 February 2024
- exercised options over 3,938 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 45 February 2024Restricted Stock Units · traded 1 February 2024 · filed 5 February 2024
- exercised options over 3,938 shares of Rhythm PharmaceuticalsSEC Form 45 February 2024Common Stock · traded 1 February 2024 · filed 5 February 2024
- ▼ sold on the open market 1,324 shares of Rhythm PharmaceuticalsSEC Form 45 February 2024Common Stock · traded 1 February 2024 · filed 5 February 2024
- exercised options over 2,400 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 429 December 2023Stock Option (Right to Buy) · traded 27 December 2023 · filed 29 December 2023
- exercised options over 6,800 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 429 December 2023Stock Option (Right to Buy) · traded 28 December 2023 · filed 29 December 2023
- exercised options over 2,400 shares of Rhythm PharmaceuticalsSEC Form 429 December 2023Common Stock · traded 27 December 2023 · filed 29 December 2023
- ▼ sold on the open market 5,015 shares of Rhythm PharmaceuticalsSEC Form 429 December 2023Common Stock · traded 27 December 2023 · filed 29 December 2023
- exercised options over 6,800 shares of Rhythm PharmaceuticalsSEC Form 429 December 2023Common Stock · traded 28 December 2023 · filed 29 December 2023
- ▼ sold on the open market 7,926 shares of Rhythm PharmaceuticalsSEC Form 429 December 2023Common Stock · traded 28 December 2023 · filed 29 December 2023
- exercised options over 27,890 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 416 November 2023Stock Option (Right to Buy) · traded 14 November 2023 · filed 16 November 2023
- exercised options over 27,890 shares of Rhythm PharmaceuticalsSEC Form 416 November 2023Common Stock · traded 14 November 2023 · filed 16 November 2023
- ▼ sold on the open market 27,890 shares of Rhythm PharmaceuticalsSEC Form 416 November 2023Common Stock · traded 14 November 2023 · filed 16 November 2023
- ▼ sold on the open market 931 shares of Rhythm PharmaceuticalsSEC Form 414 February 2023Common Stock · traded 9 February 2023 · filed 14 February 2023
- exercised options over 1,563 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 414 February 2023Restricted Stock Units · traded 11 February 2023 · filed 14 February 2023
- exercised options over 1,563 shares of Rhythm PharmaceuticalsSEC Form 414 February 2023Common Stock · traded 11 February 2023 · filed 14 February 2023
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.